Four Questions for Every Clinician Diagnosing and Monitoring Glaucoma

被引:31
作者
Hood, Donald C. [1 ,2 ]
De Moraes, Carlos G. [2 ]
机构
[1] Columbia Univ, Dept Psychol, New York, NY 10027 USA
[2] Columbia Univ, Dept Ophthalmol, Edward S Harkness Eye Inst, Bernard & Shirlee Brown Glaucoma Res Lab,Med Ctr, New York, NY 10027 USA
关键词
glaucoma; optical coherence tomography; OCT; perimetry; visual fields; 10-2; VISUAL-FIELD LOSS; OPTICAL COHERENCE TOMOGRAPHY; OF-INTEREST APPROACH; DEFECTS; DAMAGE; REGION; PROGRESSION; PREVALENCE; PERIMETRY; OCT;
D O I
10.1097/IJG.0000000000001010
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
We pose 4 questions for the clinician diagnosing and monitoring glaucoma, and supply evidence-based answers. The first question is: "When do you perform a 10-2 (2-degree grid) visual field (VF) test?" We argue the best answer is: anyone you would do, or have done, a 24-2 (6-degree grid) VF on should have both a 24-2 and a 10-2 VF within the first 2 visits. Second, "When do you perform an optical coherence tomography (OCT) scan of the macula?" We argue that, if you are performing an OCT test, then it should include both the macula and disc, either as a single scan or as 2 scans, one centered on the macula and the other on the disc. Third, "How do you know if the VF and OCT tests agree?" The poor answer is, "I use summary statistics such as 24-2 mean deviation and global or quadrant average of retinal nerve fiber layer (RNFL) thickness." It is much better to topographically compare abnormal regions on the OCT to abnormal regions on the VF. Finally, the fourth question is: "When do you look at OCT images?" We argue that, at a minimum, the clinician should be directly examining an image of the circumpapillary RNFL, and this image should be sufficiently large and with sufficient resolution so that local damage can be seen, and the segmentation evaluated.
引用
收藏
页码:657 / 664
页数:8
相关论文
共 36 条
[1]  
ANCTIL JL, 1984, ARCH OPHTHALMOL-CHIC, V102, P363
[2]   Longitudinal and Cross-sectional Analyses of Visual Field Progression in Participants of the Ocular Hypertension Treatment Study [J].
Artes, Paul H. ;
Chauhan, Balwantray C. ;
Keltner, John L. ;
Cello, Kim E. ;
Johnson, Chris A. ;
Anderson, Douglas R. ;
Gordon, Mae O. ;
Kass, Michael A. .
ARCHIVES OF OPHTHALMOLOGY, 2010, 128 (12) :1528-1532
[3]  
ASMAN P, 1994, ACTA OPHTHALMOL, V72, P303
[4]  
AULHORN E., 1967, P151
[5]  
Aulhorn E, 1977, DOC OPHTHALMOL P SER, P75
[6]   24-2 Visual Fields Miss Central Defects Shown on 10-2 Tests in Glaucoma Suspects, Ocular Hypertensives, and Early Glaucoma [J].
De Moraes, C. Gustavo ;
Hood, Donald C. ;
Thenappan, Abinaya ;
Girkin, Christopher A. ;
Medeiros, Felipe A. ;
Weinreb, Robert N. ;
Zangwill, Linda M. ;
Liebmann, Jeffrey M. .
OPHTHALMOLOGY, 2017, 124 (10) :1449-1456
[7]  
DRANCE SM, 1969, INVEST OPHTH VISUAL, V8, P84
[8]  
DRANCE SM, 1991, OPHTHALMOLOGY, V98, P1533
[9]   Modifying the Conventional Visual Field Test Pattern to Improve the Detection of Early Glaucomatous Defects in the Central 10° [J].
Ehrlich, Alyssa C. ;
Raza, Ali S. ;
Ritch, Robert ;
Hood, Donald C. .
TRANSLATIONAL VISION SCIENCE & TECHNOLOGY, 2014, 3 (06)
[10]  
HEIJL A, 1989, ACTA OPHTHALMOL, V67, P353